Copyright
        ©The Author(s) 2017.
    
    
        World J Gastroenterol. Sep 7, 2017; 23(33): 6119-6127
Published online Sep 7, 2017. doi: 10.3748/wjg.v23.i33.6119
Published online Sep 7, 2017. doi: 10.3748/wjg.v23.i33.6119
            Table 1 Basic demographic data of the study subjects
        
    | Group | n | Age (range) (yr) | Male/female | 
| Healthy | 30 | 43 (38-51) | 16/14 | 
| Mild dysplasia | 30 | 54 (42-67) | 22/18 | 
| Moderate dysplasia | 30 | 58 (40-65) | 14/16 | 
| Severe dysplasia | 30 | 63 (43-76) | 19/11 | 
| Gastric cancer | 40 | 61 (39-68) | 23/17 | 
            Table 2 Results of DNA-PKcs and ERGIC1 from proteomic analysis
        
    | Protein ID | Gene | Protein | Fold change | |||
| Mild/normal | Moderate/normal | Severe/normal | Cancer/normal | |||
| P78527 | PRKDC | DNA-dependent protein kinase catalytic subunit | 1.12 | 1.54 | 1.60 | 2.30 | 
| Q969X5 | ERGIC1 | Endoplasmic reticulum-Golgi intermediate compartment protein 1 | 1.18 | 0.84 | 0.73 | 0.46 | 
            Table 3 Results of DNA-PKcs and ERGIC1 from immunohistochemistry
        
    | Group | n | DNA-PKcs | n | ERGIC1 | ||||||
| - | + | ++ | +++ | - | + | ++ | +++ | |||
| Normal | 30 | 12 | 18 | 0 | 0 | 30 | 2 | 2 | 2 | 24 | 
| Mild | 30 | 14 | 16 | 0 | 0 | 30 | 2 | 3 | 3 | 22 | 
| Moderate | 30 | 5 | 3 | 23 | 0 | 30 | 2 | 3 | 25 | 0 | 
| Severe | 30 | 3 | 2 | 25 | 0 | 30 | 5 | 5 | 20 | 0 | 
| Cancer | 30 | 0 | 2 | 6 | 22 | 40 | 9 | 27 | 4 | 0 | 
- Citation: Wang FR, Wei YC, Han ZJ, He WT, Guan XY, Chen H, Li YM. Aberrant DNA-PKcs and ERGIC1 expression may be involved in initiation of gastric cancer. World J Gastroenterol 2017; 23(33): 6119-6127
 - URL: https://www.wjgnet.com/1007-9327/full/v23/i33/6119.htm
 - DOI: https://dx.doi.org/10.3748/wjg.v23.i33.6119
 
